Humacyte, Inc. (HUMA) Misses Q2 EPS by 24c

Humacyte, Inc. (NASDAQ: HUMA) reported Q2 EPS of ($0.48), $0.24 worse than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Humacyte, Inc. (HUMA) click here.

You May Also Be Interested In

• Cantor Fitzgerald Reiterates Overweight Rating on Onto Innovation Inc. (ONTO) Ahead of Q2 Print
• Varonis adds Claude Code and Claude Cowork to its Atlas AI security platform
• NextNRG reports $8.9M in June revenue, up 26% year-over-year